Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications

Area of Science:

• Neuroimmunology
• Autonomic Neuroscience

Background:

• Multiple sclerosis (MS) presents with diverse clinical symptoms, including autonomic nervous system (ANS) dysfunction, a significant contributor to MS-related disability.
• Understanding the interplay between the immune and autonomic systems is crucial for managing MS.

Purpose of the Study:

• To review autonomic dysfunction in individuals with multiple sclerosis.
• To explore the interactions between the immune and autonomic nervous systems in MS.
• To examine the impact of these interactions on MS disease activity.

Main Methods:

• Clinical assessment of autonomic dysfunction using tools like the Composite Autonomic Symptom Score (COMPASS-31).
• Neurophysiological testing of autonomic nervous system function.
• Molecular analysis of immune cells to identify changes in receptor expression and inflammatory pathways.

Main Results:

• Autonomic dysfunction in MS can be identified both clinically and at a molecular level.
• Both symptomatic and objectively measured autonomic dysfunction are linked to a higher risk of MS disease activity.
• Molecular alterations in immune cells, including changes in adrenergic and cholinergic pathways, are associated with MS disease activity.

Conclusions:

• Autonomic dysfunction is a clinically relevant manifestation of multiple sclerosis.
• The immune and autonomic nervous systems are interconnected and influence MS progression.
• Targeting immune-ANS interactions may offer new therapeutic strategies for multiple sclerosis.